Hongzhou Lu

Dr. Hongzhou Lu serves as the director of the Third People's Hospital of Shenzhen and the National Clinical Research Center for Infectious Diseases. He holds the position of full professor of Internal Medicine at Fudan University. He is recognizedas a Fellow of the American Academy of Microbiology and was acknowledged as one of Stanford University's top 2% scientists in 2021.

Dr. Lu earned his M.D. and Ph.D. degrees from Shanghai Medical College of Fudan University in 1999. A prominent expert in HIV and influenza in China, he has authored over 340 refereed papers in international journals. Among his notable achievements are three original articles in the New England Journal of Medicine, notably as the physician who reported the first case of H7N9 avian influenza A virus infections in humans. Dr. Lu played a vital role in clinical management, academic discourse, and public education during the H7N9 avian influenza outbreak in China.

Furthermore, Dr. Lu was among the initial group of Chinese public health experts who dedicated over 65 days to combat Ebola in Sierra Leone. Presently, he serves on the editorial boards of five international journals and holds positions on various boards of significant government and academic organizations in China. His accolades include recognition as a Leading Figure in China's Combat against SARS and the Shanghai Science and Technology Progress Award.